Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Frontiers in Oncology|October 31, 2022
Overcoming therapeutic resistance to platinum-based drugs by targeting Epithelial-Mesenchymal transitionXirui Duan, Maochao Luo, Jian Li, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|September 4, 2021
Drug resistance in colorectal cancer: An epigenetic overviewMaochao Luo, Xingyue Yang, Hai-Ning Chen, et al.
Frontiers in Oncology|May 17, 2021
Epigenetic Regulation of Epithelial to Mesenchymal Transition in the Cancer Metastatic Cascade: Implications for Cancer TherapyQiu-Luo Liu, Maochao Luo, Canhua Huang, et al.
Antioxidants (Basel, Switzerland)|June 24, 2022
Antioxidant Therapy in Cancer: Rationale and ProgressMaochao Luo, Li Zhou, Zhao Huang, et al.
Expert Review of Proteomics|March 10, 2017
Proteogenomic studies on cancer drug resistance: towards biomarker discovery and target identificationShuyue Fu, Xiang Liu, Maochao Luo, et al.
Medcomm|April 7, 2022
Redox signaling at the crossroads of human health and diseaseJing Zuo, Zhe Zhang, Maochao Luo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 13, 2023
Discovery of canine drug toceranib phosphate as a repurposed agent against human hepatocellular carcinomaLing Qiao, Siyuan Qin, Ningna Weng, et al.
Small (Weinheim an Der Bergstrasse, Germany)|November 18, 2022
Brain-Targeted HFn-Cu-REGO Nanoplatform for Site-Specific Delivery and Manipulation of Autophagy and Cuproptosis in GlioblastomaWenhui Jia, Hailong Tian, Jingwen Jiang, et al.
Medcomm|December 4, 2023
Oncofetal reprogramming in tumor development and progression: novel insights into cancer therapyJiangjun Cao, Zhe Zhang, Li Zhou, et al.
Pharmaceuticals (Basel, Switzerland)|December 23, 2022
Exploiting Polyphenol-Mediated Redox Reorientation in Cancer TherapyLei Li, Ping Jin, Yueyue Guan, et al.
Pageof 3